WEST PHARMACEUTICAL SERVICES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 3.70% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-03-31 was 3.70%, a 17.78% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-03-31 was 4.50%, a 4.65% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-03-31 was 4.30%, a 4.88% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 4.10%, a 127.78% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month |
|---|---|---|---|
| 2026-06-30 | 3.70% 10-Q · filed 2026-07-23 | ||
| 2026-03-31 | 3.70% 10-Q · filed 2026-04-23 | ||
| 2025-09-30 | 4.30% 10-Q · filed 2025-10-23 | ||
| 2025-06-30 | 4.40% 10-Q · filed 2025-07-24 | ||
| 2025-03-31 | 4.50% 10-Q · filed 2025-04-24 | ||
| 2024-09-30 | 4.30% 10-Q · filed 2024-10-24 | ||
| 2024-06-30 | 4.30% 10-Q · filed 2024-07-25 | ||
| 2024-03-31 | 4.30% 10-Q · filed 2024-04-25 | ||
| 2023-09-30 | 4.10% 10-Q · filed 2023-10-26 | ||
| 2023-06-30 | 4.10% 10-Q · filed 2023-07-27 | ||
| 2023-03-31 | 4.10% 10-Q · filed 2023-04-27 | ||
| 2022-09-30 | 1.80% 10-Q · filed 2022-10-27 | ||
| 2022-06-30 | 1.80% 10-Q · filed 2022-07-28 | ||
| 2022-03-31 | 1.80% 10-Q · filed 2022-04-28 | ||
| 2021-09-30 | 0.70% 10-Q · filed 2021-10-28 | ||
| 2021-06-30 | 0.70% 10-Q · filed 2021-07-30 | ||
| 2021-03-31 | 0.70% 10-Q · filed 2021-04-30 | ||
| 2020-09-30 | 1.30% 10-Q · filed 2020-10-23 | ||
| 2020-06-30 | 1.40% 10-Q · filed 2020-07-24 | ||
| 2020-03-31 | 1.40% 10-Q · filed 2020-04-24 | ||
| 2019-09-30 | 2.30% 10-Q · filed 2019-10-29 | ||
| 2019-06-30 | 2.30% 10-Q · filed 2019-07-29 | ||
| 2019-03-31 | 2.30% 10-Q · filed 2019-05-08 | ||
| 2018-09-30 | 2.68% 10-Q · filed 2018-10-30 | ||
| 2018-06-30 | 2.69% 10-Q · filed 2018-07-31 | ||
| 2018-03-31 | 2.70% 10-Q · filed 2018-05-08 | ||
| 2017-09-30 | 2.04% 10-Q · filed 2017-10-31 | ||
| 2017-06-30 | 2.05% 10-Q · filed 2017-08-01 | ||
| 2017-03-31 | 2.05% 10-Q · filed 2017-05-05 | ||
| 2016-09-30 | 1.43% 10-Q · filed 2016-10-31 | ||
| 2016-06-30 | 1.39% 10-Q · filed 2016-08-01 | ||
| 2016-03-31 | 1.35% 10-Q · filed 2016-05-06 | ||
| 2015-09-30 | 1.61% 10-Q · filed 2015-11-02 | ||
| 2015-06-30 | 1.61% 10-Q · filed 2015-08-03 | ||
| 2015-03-31 | 1.67% 10-Q · filed 2015-05-06 | ||
| 2014-09-30 | 1.58% 10-Q · filed 2014-11-03 | ||
| 2014-06-30 | 1.57% 10-Q · filed 2014-08-01 | ||
| 2014-03-31 | 1.57% 10-Q · filed 2014-05-08 | ||
| 2013-09-30 | 0.89% 10-Q · filed 2013-11-04 | ||
| 2013-06-30 | 0.89% 10-Q · filed 2013-08-05 | ||
| 2013-03-31 | 0.89% 10-Q · filed 2013-05-06 | ||
| 2012-09-30 | 0.90% 10-Q · filed 2012-11-05 | ||
| 2012-03-31 | 0.92% 10-Q · filed 2012-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |